Hospital & Healthcare Management April 26, 2024
Introduction
The proliferation of substandard or falsified drugs poses a significant threat to public health worldwide, affecting millions of people and exacerbating existing health disparities. Certain populations are particularly vulnerable to the consequences of these counterfeit pharmaceuticals, facing heightened risks of treatment failure, adverse reactions, and even death. This article explores the groups most susceptible to the impact of substandard or falsified drugs and provides insights into the global efforts to address this critical issue.
Vulnerable Populations
Low-Income Countries
One of the primary cohorts vulnerable to substandard or falsified drugs is found in low-income countries with limited regulatory infrastructure and resources. These nations often struggle to enforce stringent pharmaceutical quality control measures, making it easier for counterfeit drugs to infiltrate...
Today's Sponsors
Today's Sponsor